BioVersys AG (BIOV.XSWX) Financials
All currency values in CHF millions unless otherwise noted
| Income Statement | DEC 2025 | DEC 2024 |
|---|---|---|
| Revenues | ||
| Revenue | CHF 1 | CHF 0 |
| Cost of Revenue | CHF 4 | CHF 4 |
| Gross Profit | -CHF 3 | -CHF 4 |
| Total Operating Expenses | CHF 17 | CHF 15 |
| Operating Income | -CHF 20 | -CHF 19 |
| Non-Operating | ||
| Net Interest Expense | -CHF 1 | -CHF 1 |
| Income Tax Expense | CHF 0 | CHF 0 |
| Net Income | ||
| Net Income | -CHF 22 | -CHF 19 |
| Per Share Data | ||
| Revenue Per Share | CHF 0.14 | CHF 0.00 |
| EPS (Basic) | -CHF 3.89 | -CHF 3.16 |
| EPS (Diluted) | -CHF 3.89 | -CHF 3.16 |
| Shares Outstanding | 5.6M | 5.9M |
BioVersys (BIOV.XSWX) financials: revenue, profit and margins
BioVersys (BIOV.XSWX) generated about CHF 800,000.00 in revenue and -CHF 22 million in net income (a -2,728.8% net margin) over the trailing twelve months. Figures are from company filings; this is analysis, not investment advice.
Frequently asked
What is BioVersys's (BIOV.XSWX) revenue?+
BioVersys generated about CHF 800,000.00 in revenue over the trailing twelve months. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is BioVersys profitable?+
BioVersys reported about -CHF 22 million in net loss over the trailing twelve months, a net margin of roughly -2,728.8%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are BioVersys's profit margins?+
BioVersys runs a gross margin of about -386.6%, an operating margin of about -2,495.4%, a net margin of about -2,728.8%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.